TABLE 1.
Summary and comparison of inflammation markers recorded during the bronchiectasis study
| Parameter | Stable condition | Exacerbation | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Total | Men | Women | Total | Men | Women | |
| CRP, mg/L | 6.2 (0.0–24.0) | 5.0 (0.0–18.0) | 7.3 (0.0–24.0) | 62.5 (10.0–141.0) | 44.6 (14.0–70.0) | 67.3 (10.0–141.0) |
| WBC, ×109/L | 7.136 (3.990–12.920) | 7.207 (3.990–12.450) | 7.082 (4.550–12.920) | 8.301 (4.870–12.580) | 7.522 (4.870–10.900) | 8.585 (6.310–12.580) |
| Comparison of CRP and WBC between exacerbation and stable condition periods | P | Mean | 95% CI | |||
|
| ||||||
| CRP, mg/L | <0.0001 | 5.62 | 42.32–70.08 | |||
| WBC, ×109/L | 0.098 | 1.165 | −0.227–2.558 | |||
Data presented as mean (range). CRP C-reactive protein; WBC White blood cells